VHCP Management II’s Bellerophon Therapeutics, Inc. BLPH Stock Holding History

VHCP Management II’s Portfolio BLPH Stock Details BLPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$230K	Sell	43,939 -232,686	-84%	-$1.48M	0.06%	19
2019 Q3	$2M	Hold	276,625	–	–	0.76%	18
2019 Q2	$2.49M	Hold	276,625	–	–	0.79%	18
2019 Q1	$2.71M	Hold	276,625	–	–	0.79%	16
2018 Q4	$3.33M	Hold	276,625	–	–	1.43%	11
2018 Q3	$4.48M	Hold	276,625	–	–	1.2%	17
2018 Q2	$10M	Hold	276,625	–	–	3.01%	11
2018 Q1	$8.63M	Hold	276,625	–	–	2.08%	13
2017 Q4	$9.67M	Hold	276,625	–	–	2.32%	11
2017 Q3	$4.72M	Buy	+276,625	New	+$5.14M	1.3%	13

Other funds holding BLPH

NMVA

New Mountain Vantage Advisers New York $4.33B AUM 35.3% 1-Year Est. Return

PCM

Puissance Capital Management New York $17.3M AUM 149.36% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VMI

VHCP Management III New York $504M AUM 683.12% 1-Year Est. Return

Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

VHCP Management II's BLPH Position: Q4 2019 in Review

VHCP Management II reduced its Bellerophon Therapeutics, Inc. (BLPH) stake by 84% in Q4 2019, selling an estimated $1.48M and leaving 43,939 shares worth $230K. The position accounts for 0.06% of the portfolio, ranked #19.

VHCP Management II first reported a position in BLPH in Q3 2017 and has held it in 10 quarters since. The position peaked at $10M in Q2 2018. 19 funds tracked by Wall St. Rank hold BLPH as of Q4 2019.

VHCP Management II held 43,939 shares of Bellerophon Therapeutics, Inc. worth $230K as of Q4 2019.
VHCP Management II sold 232,686 Bellerophon Therapeutics, Inc. shares in Q4 2019, an estimated $1.48M.
Bellerophon Therapeutics, Inc. made up 0.06% of VHCP Management II's portfolio in Q4 2019, its #19 holding.
VHCP Management II first reported a position in Bellerophon Therapeutics, Inc. in Q3 2017 and has held it in 10 quarters since.
VHCP Management II's Bellerophon Therapeutics, Inc. position peaked at $10M in Q2 2018.
19 funds tracked by Wall St. Rank held Bellerophon Therapeutics, Inc. as of Q4 2019.

Based on VHCP Management II's 13F filing for Q4 2019, filed 13 Feb 2020.